1. Home
  2. ALTO vs TLSI Comparison

ALTO vs TLSI Comparison

Compare ALTO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alto Ingredients Inc.

ALTO

Alto Ingredients Inc.

HOLD

Current Price

$3.73

Market Cap

315.7M

Sector

Industrials

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.43

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTO
TLSI
Founded
2003
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.7M
270.2M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ALTO
TLSI
Price
$3.73
$4.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $7.00
AVG Volume (30 Days)
★ 1.1M
231.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 119.51
N/A
EPS
★ 0.20
N/A
Revenue
★ $917,927,000.00
$45,151,000.00
Revenue This Year
$6.66
$35.45
Revenue Next Year
$0.43
$37.58
P/E Ratio
$18.70
★ N/A
Revenue Growth
N/A
★ 53.41
52 Week Low
$0.99
$2.20
52 Week High
$6.11
$7.95

Technical Indicators

Market Signals
Indicator
ALTO
TLSI
Relative Strength Index (RSI) 34.32 35.40
Support Level $2.39 $4.28
Resistance Level $4.17 $4.47
Average True Range (ATR) 0.14 0.36
MACD -0.00 -0.04
Stochastic Oscillator 13.27 2.32

Price Performance

Historical Comparison
ALTO
TLSI

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: